{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:48:00Z","timestamp":1789606080599,"version":"build-2803163510"},"reference-count":140,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Colchicine has emerged as a prominent anti-inflammatory candidate in cardiovascular medicine, supported by a hierarchy of evidence spanning chronic and acute coronary syndromes, post-myocardial infarction care, revascularization, atrial fibrillation, pericardial disease, heart failure, peripheral arterial disease, and mechanistic translational models. Across this literature, the most mature study architecture and the strongest clinical support are derived from completed randomized trials in chronic coronary disease and secondary prevention, where colchicine has been shown to prevent major cardiovascular events (MACEs) when added to standard of care. The clearest clinical benefits are the reduction in non-fatal ischemic events in atherosclerotic disease, prevention of recurrent pericarditis and postoperative atrial fibrillation, and attenuation of inflammatory and plaque-related markers. By contrast, mixed or lower-tier evidence renders its application less consistent in acute coronary syndromes, ST-elevation MI (STEMI), percutaneous coronary intervention (PCI)-related hard outcomes, and heart failure, while a definitive mortality benefit has not been demonstrated. Overall, colchicine is best understood as a targeted clinical adjunct whose value depends heavily on precise indication, timing, dose, gastrointestinal tolerability, and the maturity of the supporting evidence.<\/jats:p>","DOI":"10.3390\/ijms27104419","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:40:31Z","timestamp":1779115231000},"page":"4419","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Colchicine in Cardiovascular Disease: Evidence Structure, Clinical Efficacy, Safety, and Translational Positioning Across Cardiovascular Syndromes"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5637-8729","authenticated-orcid":false,"given":"Hossein","family":"Omidian","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi G.","family":"Cubeddu","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0410-7407","authenticated-orcid":false,"given":"Erma J.","family":"Gill","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0154-6342","authenticated-orcid":false,"given":"Luigi X.","family":"Cubeddu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tcm.2020.10.007","article-title":"Colchicine for the treatment of coronary artery disease","volume":"31","author":"Aimo","year":"2021","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1093\/eurheartj\/suab084","article-title":"Anti-inflammatory therapy in ischaemic heart disease: From canakinumab to colchicine","volume":"23","author":"Andreotti","year":"2021","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_3","first-page":"665","article-title":"ANMCO position paper: Colchicine as a therapeutic agent in coronary syndromes","volume":"24","author":"Imazio","year":"2023","journal-title":"G. Ital. Cardiol."},{"key":"ref_4","unstructured":"(2026, April 06). PubChem CID, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/6167#section=2D-Structure."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100610","DOI":"10.1016\/j.ahjo.2025.100610","article-title":"Efficacy and safety of colchicine in patients with coronary artery disease: An updated meta-analysis of randomized controlled trials","volume":"59","author":"Ahmed","year":"2025","journal-title":"Am. Heart J. Plus Cardiol. Res. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"xvag058","DOI":"10.1093\/eschf\/xvag058","article-title":"Colchicine in patients with chronic inflammatory cardiomyopathy: Rationale and design of the CMP-MYTHiC","volume":"13","author":"Ammirati","year":"2026","journal-title":"ESC Heart Fail."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2459\/JCM.0000000000001744","article-title":"Colchicine for prevention of major adverse cardiovascular events: A meta-analysis of randomized clinical trials","volume":"26","author":"Ballacci","year":"2025","journal-title":"J. Cardiovasc. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000512772","article-title":"Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol\u2014The COVERT-MI Study","volume":"146","author":"Bresson","year":"2021","journal-title":"Cardiology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ahj.2023.01.018","article-title":"Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial","volume":"259","author":"Conen","year":"2023","journal-title":"Am. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ahj.2024.06.007","article-title":"Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2 \u00d7 2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarction","volume":"275","author":"Lee","year":"2024","journal-title":"Am. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ahj.2024.08.022","article-title":"Low-dose colchicine for the prevention of cardiovascular events after percutaneous coronary intervention: Rationale and design of the COL BE PCI trial","volume":"278","author":"Kautbally","year":"2024","journal-title":"Am. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e041007","DOI":"10.1161\/JAHA.125.041007","article-title":"Comparative Efficacy and Safety of Colchicine and Anti-Interleukin-1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials","volume":"14","author":"Ehsan","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40256-025-00743-y","article-title":"Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide","volume":"26","author":"Li","year":"2026","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ahj.2025.07.010","article-title":"The effects of low-dose colchicine on the progression of aortic valve stenosis: Rationale, design, and baseline characteristics of the Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial","volume":"290","author":"Mohammadnia","year":"2025","journal-title":"Am. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1093\/eurheartj\/ehae538","article-title":"Colchicine in acutely decompensated heart failure: The COLICA trial","volume":"45","author":"Delgado","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/eurjpc\/zwaf302","article-title":"The efficacy and safety of low dose colchicine in atherosclerotic cardiovascular disease: A systematic review and meta-analysis","volume":"33","author":"Tucker","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10557-021-07240-9","article-title":"Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study","volume":"36","author":"Montarello","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ahj.2024.07.005","article-title":"Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial-rationale and design","volume":"277","author":"Verghese","year":"2024","journal-title":"Am. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11239-020-02121-8","article-title":"Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel","volume":"50","author":"Cirillo","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_20","first-page":"100066","article-title":"Microtubule destabilization with colchicine increases the work output of myocardial slices","volume":"7","author":"Hancock","year":"2024","journal-title":"J. Mol. Cell. Cardiol. Plus"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Pennings, G.J., Reddel, C.J., Chen, V.M., Gnanenthiran, S.R., and Kritharides, L. (2023). Perspective: Collagen induced platelet activation via the GPVI receptor as a primary target of colchicine in cardiovascular disease. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.1104744"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e018993","DOI":"10.1161\/JAHA.120.018993","article-title":"Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention","volume":"10","author":"Vaidya","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"119239","DOI":"10.1016\/j.atherosclerosis.2025.119239","article-title":"Experimental evidence on colchicine\u2019s mode of action in human carotid artery plaques","volume":"406","author":"Steenbuck","year":"2025","journal-title":"Atherosclerosis"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/ejhf.3300","article-title":"Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA)","volume":"26","author":"Villota","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/heartjnl-2024-325527","article-title":"Effect of low-dose colchicine on pericoronary inflammation and coronary plaque composition in chronic coronary disease: A subanalysis of the LoDoCo2 trial","volume":"111","author":"Fiolet","year":"2025","journal-title":"Heart"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Mohammadnia, N., Los, J., Opstal, T.S.J., Fiolet, A.T.L., Eikelboom, J.W., Mosterd, A., Nidorf, S.M., Budgeon, C.A., Tijssen, J.G.P., and Thompson, P.L. (2023). Colchicine and diabetes in patients with chronic coronary artery disease: Insights from the LoDoCo2 randomized controlled trial. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1244529"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.jacc.2025.08.025","article-title":"Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis An Exploratory Substudy of the LoDoCo2 Trial","volume":"86","author":"Mohammadnia","year":"2025","journal-title":"JACC-J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2021.08.005","article-title":"Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy","volume":"334","author":"Silvis","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_29","first-page":"223","article-title":"Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT","volume":"14","author":"Legault","year":"2021","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2022.06.028","article-title":"Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies","volume":"363","author":"Sun","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2022.12.026","article-title":"Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial","volume":"372","author":"Opstal","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"41","author":"Bouabdallaoui","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ahj.2024.09.006","article-title":"Exploration of the regional effects of colchicine in the LoDoCo2 trial","volume":"278","author":"Budgeon","year":"2024","journal-title":"Am. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2021.06.037","article-title":"Colchicine in Patients with Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome","volume":"78","author":"Opstal","year":"2021","journal-title":"JACC-J. Am. Coll. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/eurjpc\/zwae355","article-title":"The effects of colchicine on lipoprotein(a)- and oxidized phospholipid-associated cardiovascular disease risk","volume":"32","author":"Mohammadnia","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e038687","DOI":"10.1161\/JAHA.124.038687","article-title":"Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial","volume":"14","author":"Mohammadnia","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"132972","DOI":"10.1016\/j.ijcard.2025.132972","article-title":"Effect of low dose colchicine on long term recurrence after atrial fibrillation ablation","volume":"423","author":"Aslam","year":"2025","journal-title":"Int. J. Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e01238","DOI":"10.1161\/CIRCEP.123.012387","article-title":"Colchicine to Prevent Atrial Fibrillation Recurrence After Catheter Ablation: A Randomized, Placebo-Controlled Trial","volume":"17","author":"Benz","year":"2024","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/FJC.0000000000001317","article-title":"Preprocedural Colchicine in Patients with Acute ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial (PodCAST-PCI)","volume":"80","author":"Hosseini","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/CIRCINTERVENTIONS.120.009992","article-title":"Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention The COPE-PCI Pilot Trial","volume":"14","author":"Cole","year":"2021","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1098429","DOI":"10.1155\/2022\/1098429","article-title":"COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): Coronary Microvascular Physiology Pilot Substudy","volume":"2022","author":"Cole","year":"2022","journal-title":"J. Interv. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.carrev.2021.09.006","article-title":"COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): A Descriptive Cytokine Pilot Sub-Study","volume":"39","author":"Cole","year":"2022","journal-title":"Cardiovasc. Revascularization Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/jce.15941","article-title":"Colchicine usage for prevention of post atrial fibrillation ablation pericarditis in patients undergoing high-power short-duration ablation","volume":"34","author":"Iqbal","year":"2023","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e008717","DOI":"10.1161\/CIRCINTERVENTIONS.119.008717","article-title":"Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention COLCHICINE-PCI Randomized Trial","volume":"13","author":"Shah","year":"2020","journal-title":"Circ. Cardiovasc. Interv."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e043791","DOI":"10.1161\/JAHA.125.043791","article-title":"Preoperative Colchicine and Conduction Disturbances After Transcatheter Aortic Valve Implantation: A US Retrospective Cohort Analysis","volume":"14","author":"Abdelsayed","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/heartjnl-2023-323484","article-title":"Efficacy and safety of colchicine for the treatment of myopericarditis","volume":"110","author":"Collini","year":"2024","journal-title":"Heart"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"118563","DOI":"10.1016\/j.atherosclerosis.2024.118563","article-title":"Association of colchicine use with cardiovascular and limb events in peripheral artery disease: Insights from a retrospective cohort study","volume":"398","author":"Tramujas","year":"2024","journal-title":"Atherosclerosis"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s40256-023-00612-6","article-title":"Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective Study","volume":"23","author":"Campbell","year":"2023","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Yeh, J.J., Hung, T.W., Lin, C.L., Chen, T.T., Liw, P.X., Yu, Y.L., and Kao, C.H. (2022). Colchicine Is a Weapon for Managing the Heart Disease Among Interstitial Lung Disease with Viral Infection: Have We Found the Holy Grail?. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.925211"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.124.069808","article-title":"Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial","volume":"150","author":"Yu","year":"2024","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction","volume":"144","author":"Mewton","year":"2021","journal-title":"Circulation"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2459\/JCM.0000000000001157","article-title":"Adverse events of colchicine for cardiovascular diseases: A comprehensive meta-analysis of 14,188 patients from 21 randomized controlled trials","volume":"22","author":"Andreis","year":"2021","journal-title":"J. Cardiovasc. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/eurheartj\/ehaf210","article-title":"Colchicine for secondary prevention of vascular events: A meta-analysis of trials","volume":"46","author":"Poorthuis","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Ge, P.B., Fu, Y., Su, Q., Jin, M.D., Guo, L., Miao, C.L., Zhu, S., Zhuang, J.Q., Zhang, Z., and Hong, J. (2022). Colchicine for prevention of post-operative atrial fibrillation: Meta-analysis of randomized controlled trials. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.1032116"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e044241","DOI":"10.1161\/JAHA.125.044241","article-title":"Colchicine in Patients with Recent Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"15","author":"Moiz","year":"2026","journal-title":"J. Am. Heart Assoc."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/FJC.0000000000001706","article-title":"Colchicine in Acute Coronary Syndromes: A Meta-Analysis of 12,602 Patients","volume":"86","author":"Cappannoli","year":"2025","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40119-022-00298-y","article-title":"Colchicine in the Management of Acute Coronary Syndrome: A Meta-analysis","volume":"12","author":"Nogic","year":"2023","journal-title":"Cardiol. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"840","DOI":"10.2459\/JCM.0000000000001554","article-title":"Colchicine added to standard therapy further reduces fibrosis in pigs with myocardial infarction","volume":"24","author":"Aimo","year":"2023","journal-title":"J. Cardiovasc. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12265-020-09974-7","article-title":"Effects of Colchicine on Atherosclerotic Plaque Stabilization: A Multimodality Imaging Study in an Animal Model","volume":"14","author":"Cecconi","year":"2021","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Li, H.Q., Yang, H.F., Qin, Z.B., Wang, Q., and Li, L. (2024). Colchicine ameliorates myocardial injury induced by coronary microembolization through suppressing pyroptosis via the AMPK\/SIRT1\/NLRP3 signaling pathway. BMC Cardiovasc. Disord., 24.","DOI":"10.1186\/s12872-023-03697-8"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10557-022-07326-y","article-title":"Colchicine Inhibits NETs and Alleviates Cardiac Remodeling after Acute Myocardial Infarction","volume":"38","author":"Li","year":"2024","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5299370","DOI":"10.1155\/2022\/5299370","article-title":"Colchicine Does Not Reduce Abdominal Aortic Aneurysm Growth in a Mouse Model","volume":"2022","author":"Phie","year":"2022","journal-title":"Cardiovasc. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jacep.2024.02.019","article-title":"Atrial Fibrosis and Inflammation in Postoperative Atrial Fibrillation Comparative Effects of Amiodarone, Colchicine, or Exosomes","volume":"10","author":"Parent","year":"2024","journal-title":"JACC-Clin. Electrophysiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1536\/ihj.23-448","article-title":"Colchicine Prevents Cardiac Rupture in Mice with Myocardial Infarction by Inhibiting P53-Dependent Apoptosis","volume":"65","author":"Shen","year":"2024","journal-title":"Int. Heart J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s12350-021-02589-8","article-title":"The effect of Vitamin-K1 and Colchicine on Vascular Calcification Activity in subjects with Diabetes Mellitus (ViKCoVaC): A double-blind 2x2 factorial randomized controlled trial","volume":"29","author":"Bellinge","year":"2022","journal-title":"J. Nucl. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e002599","DOI":"10.1136\/openhrt-2023-002599","article-title":"Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis","volume":"11","author":"Collini","year":"2024","journal-title":"Open Heart"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2020.03.069","article-title":"Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study","volume":"311","author":"Lazaros","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Rabbani, A., Rafique, A., Wang, X.Y., Campbell, D., Wang, D.N., Brownell, N., Capdevilla, K., Garabedian, V., Chaparro, S., and Herrera, R. (2022). Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients with Coronavirus Disease-19. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.876718"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1017\/S104795112200186X","article-title":"Colchicine in post-operative Fontan patients","volume":"33","author":"Goldstein","year":"2023","journal-title":"Cardiol. Young"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2459\/JCM.0000000000001556","article-title":"Edoxaban and\/or colchicine in outpatients with COVID-19: Rationale and design of the CONVINCE trial","volume":"24","author":"Landi","year":"2023","journal-title":"J. Cardiovasc. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e002360","DOI":"10.1136\/openhrt-2023-002360","article-title":"Colchicine in patients with heart failure and preserved left ventricular ejection fraction: Rationale and design of a prospective, randomised, open-label, crossover clinical trial","volume":"10","author":"Shchendrygina","year":"2023","journal-title":"Open Heart"},{"key":"ref_72","first-page":"e70415","article-title":"Colchicine-Treated Familial Mediterranean Fever Patients Are Associated with a Lower Prevalence of Mitral Annular Calcification","volume":"43","author":"Durak","year":"2026","journal-title":"Echocardiogr. A J. Cardiovasc. Ultrasound Allied Tech."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/CIRCULATIONAHA.125.077665","article-title":"Low-Dose Colchicine Attenuates Clonal Hematopoiesis in COLCOT","volume":"153","author":"Tardif","year":"2026","journal-title":"Circulation"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in Patients with Acute Coronary Syndrome the Australian COPS Randomized Clinical Trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e002474","DOI":"10.1136\/openhrt-2023-002474","article-title":"Colchicine in acute myocardial infarction: Cardiovascular events at 1-year follow up","volume":"11","author":"Bouleti","year":"2024","journal-title":"Open Heart"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Akrami, M., Izadpanah, P., Bazrafshan, M., Hatamipour, U., Nouraein, N., Drissi, H.B., and Manafi, A. (2021). Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence, a randomized placebo-control trial. BMC Cardiovasc. Disord., 21.","DOI":"10.1186\/s12872-021-02393-9"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jacep.2023.02.003","article-title":"Prophylactic Colchicine After Radiofrequency Ablation of Atrial Fibrillation","volume":"9","author":"Ahmed","year":"2023","journal-title":"JACC-Clin. Electrophysiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"oeae062","DOI":"10.1093\/ehjopen\/oeae062","article-title":"Colchicine for cardiovascular and limb risk reduction in Medicare beneficiaries with peripheral artery disease: Emulation of target trials","volume":"4","author":"Heindel","year":"2024","journal-title":"Eur. Heart J. Open"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.amjcard.2025.11.001","article-title":"Clinical Use and Effectiveness of Colchicine for Secondary Prevention Following Acute Myocardial Infarction","volume":"259","author":"Marano","year":"2026","journal-title":"Am. J. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/eurjpc\/zwaf513","article-title":"Ischaemic cardiovascular risk with allopurinol and protective effect of colchicine in gout: A Dutch nationwide pharmaco-epidemiological study","volume":"33","author":"Peeters","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_81","first-page":"843","article-title":"Efficacy and safety of colchicine and spironolactone after myocardial infarction: The CLEAR-SYNERGY trial in perspective","volume":"13","author":"Tardif","year":"2024","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s44161-024-00600-2","article-title":"Implications and limitations of the CLEAR-SYNERGY trial for the use of low-dose colchicine in cardiovascular disease","volume":"4","author":"Misra","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jacc.2025.08.047","article-title":"Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A report for the American College of Cardiology","volume":"87","author":"Mensah","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/eurjpc\/zwab045","article-title":"Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: A systematic review and meta-analysis on 12 869 patients","volume":"28","author":"Andreis","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/eurheartj\/ehaf174","article-title":"Long-term trials of colchicine for secondary prevention of vascular events: A meta-analysis","volume":"46","author":"Samuel","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/FJC.0000000000001533","article-title":"Efficacy and Safety of Colchicine for the Prevention of Postoperative Atrial Fibrillation Among Patients Undergoing Major Cardiothoracic Surgery: A Meta-analysis and Meta-regression of Randomized Controlled Trials","volume":"83","author":"Rivera","year":"2024","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"8317011","DOI":"10.1155\/2022\/8317011","article-title":"Effect of Treatment with Colchicine after Acute Coronary Syndrome on Major Cardiovascular Events: A Systematic Review and Meta-Analysis of Clinical Trials","volume":"2022","author":"Razavi","year":"2022","journal-title":"Cardiovasc. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e001887","DOI":"10.1136\/openhrt-2021-001887","article-title":"Colchicine for symptomatic coronary artery disease after percutaneous coronary intervention","volume":"9","author":"Aw","year":"2022","journal-title":"Open Heart"},{"key":"ref_89","first-page":"110","article-title":"Clinical outcomes of patients undergoing percutaneous coronary intervention treated with colchicine","volume":"5","author":"Levine","year":"2023","journal-title":"REC-Interv. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1532\/hsf.3609","article-title":"Colchicine for Coronary Heart Disease: A Meta-Analysis of Randomized Controlled Trials","volume":"24","author":"Liao","year":"2021","journal-title":"Heart Surg. Forum"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.amjcard.2020.10.043","article-title":"Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease","volume":"140","author":"Xia","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.hlc.2021.09.017","article-title":"Colchicine for Secondary Prevention o f Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials","volume":"31","author":"Xu","year":"2022","journal-title":"Heart Lung Circ."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cjco.2023.02.005","article-title":"Cost-Effectiveness of Colchicine for Recurrent Cardiovascular Events","volume":"5","author":"Boczar","year":"2023","journal-title":"CJC Open"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ehjqcco\/qcae021","article-title":"Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands","volume":"11","author":"Fiolet","year":"2024","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"100580","DOI":"10.1016\/j.ahjo.2025.100580","article-title":"Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery","volume":"57","author":"Ponnana","year":"2025","journal-title":"Am. Heart J. Plus Cardiol. Res. Pract."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/ehjqcco\/qcaa045","article-title":"Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"7","author":"Samuel","year":"2021","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"101622","DOI":"10.1016\/j.jacadv.2025.101622","article-title":"Potential Impact of Colchicine on Atherosclerotic Cardiovascular Disease in the United States","volume":"4","author":"Buckley","year":"2025","journal-title":"JACC-Adv."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/eurjpc\/zwad221","article-title":"Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease","volume":"30","author":"Burger","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1253\/circj.CJ-24-0854","article-title":"Effect of Oral Administration of Colchicine on Progression of Aortic Aneurysm in Mice","volume":"89","author":"Okawa","year":"2025","journal-title":"Circ. J."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ehf2.13845","article-title":"Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis","volume":"9","author":"Pappritz","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e025266","DOI":"10.1161\/JAHA.122.025266","article-title":"Colchicine Ameliorates Dilated Cardiomyopathy Via SIRT2-Mediated Suppression of NLRP3 Inflammasome Activation","volume":"11","author":"Sun","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_102","first-page":"259","article-title":"Colchicine Attenuates Microvascular Obstruction after Myocardial Ischemia-Reperfusion Injury by Inhibiting the Proliferation of Neutrophil in Bone Marrow","volume":"39","author":"Tan","year":"2025","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11239-021-02585-2","article-title":"Effects of colchicine on tissue factor in oxLDL-activated T-lymphocytes","volume":"53","author":"Cirillo","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Ul Abideen, Z., Pathak, D.R., Sabanci, R., Manu, M., and Abela, G.S. (2024). The effect of colchicine on cholesterol crystal formation, expansion and morphology: A potential mechanism in atherosclerosis. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1345521"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/jamacardio.2022.5608","article-title":"Association of Dapagliflozin Use with Clinical Outcomes and the Introduction of Uric Acid-Lowering Therapy and Colchicine in Patients with Heart Failure with and Without Gout A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVER","volume":"8","author":"Butt","year":"2023","journal-title":"JAMA Cardiol."},{"key":"ref_106","first-page":"326","article-title":"Benefit-risk of colchicine and spironolactone in acute myocardial infarction: A prespecified generalised pairwise comparisons analysis of the CLEAR trial","volume":"112","author":"Jolly","year":"2025","journal-title":"Heart"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10557-024-07622-9","article-title":"Comparative Efficacy of Colchicine and Intensive Low-density Lipoprotein Cholesterol Lowering in Patients with Atherosclerotic Diseases receiving Statins: A Network Meta-analysis of Randomized Controlled Trials","volume":"39","author":"Ou","year":"2025","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacep.2023.01.037","article-title":"Impact of Colchicine Monotherapy on the Risk of Acute Pericarditis Following Atrial Fibrillation Ablation","volume":"9","author":"Mohanty","year":"2023","journal-title":"JACC-Clin. Electrophysiol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Shvartz, V., Le, T., Enginoev, S., Sokolskaya, M., Ispiryan, A., Shvartz, E., Nudel, D., Araslanova, N., Petrosyan, A., and Donakanyan, S. (2022). Colchicine in Cardiac Surgery: The COCS Randomized Clinical Trial. J. Cardiovasc. Dev. Dis., 9.","DOI":"10.3390\/jcdd9100363"},{"key":"ref_110","first-page":"399","article-title":"The effect of colchicine on the echocardiographic constrictive physiology after coronary artery bypass graft surgery","volume":"37","author":"Shojaeifard","year":"2020","journal-title":"Echocardiogr. J. Cardiovasc. Ultrasound Allied Tech."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"39","DOI":"10.18087\/cardio.2023.7.n2229","article-title":"Systemic inflammatory response in cardiac surgery: Possibilities of using colchicine","volume":"63","author":"Diakova","year":"2023","journal-title":"Kardiologiya"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Jang, J.Y., Suh, Y., Kim, C., Byoun, J.T., Yun, K.H., Lee, J.H., Jeon, K.H., Cho, S., Yoon, H.J., and Kim, J.W. (2025). Efficacy and safety of mono antiplatelet therapy with colchicine in acute coronary syndrome patients following percutaneous coronary intervention: Rationale and design of the MACT II trial. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1662392"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2459\/JCM.0000000000001389","article-title":"Rationale and design of COLchicine On-admission to Reduce inflammation in Acute Coronary Syndrome (COLOR-ACS) study","volume":"24","author":"Toso","year":"2023","journal-title":"J. Cardiovasc. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jcin.2023.05.035","article-title":"P2Y12 Inhibitor Monotherapy Combined with Colchicine Following PCI in ACS Patients the MACT Pilot Study","volume":"16","author":"Lee","year":"2023","journal-title":"JACC-Cardiovasc. Interv."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/1074248420922793","article-title":"A MicroRNA Signature in Acute Coronary Syndrome Patients and Modulation by Colchicine","volume":"25","author":"Barraclough","year":"2020","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.hrtlng.2025.04.022","article-title":"Efficacy of colchicine in lower extremity peripheral arterial disease: A meta-analysis","volume":"73","author":"Jain","year":"2025","journal-title":"Heart Lung"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"206","DOI":"10.34172\/jcvtr.025.33169","article-title":"Effects of colchicine on depression scale scores of patients with chronic heart failure with reduced ejection fraction: A randomized clinical trial","volume":"17","author":"Khiali","year":"2025","journal-title":"J. Cardiovasc. Thorac. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacep.2024.10.033","article-title":"Intrapericardial Corticosteroids and Colchicine Prevent Pericarditis and Atrial Fibrillation After Epicardial Ablation of Ventricular Arrhythmias","volume":"11","author":"Romero","year":"2025","journal-title":"JACC-Clin. Electrophysiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"ezae364","DOI":"10.1093\/ejcts\/ezae364","article-title":"Colchicine prevents perioperative myocardial injury in cardiac surgery by inhibiting the formation of neutrophil extracellular traps: Evidence from rat models","volume":"66","author":"Pan","year":"2024","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e033700","DOI":"10.1161\/JAHA.123.033700","article-title":"Low-Dose Colchicine Ameliorates Doxorubicin Cardiotoxicity via Promoting Autolysosome Degradation","volume":"13","author":"Peng","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.amjcard.2024.09.003","article-title":"Colchicine in Patients with Coronary Disease Who Underwent Coronary Artery Bypass Surgery: A Meta- Analysis of Randomized Controlled Trials","volume":"231","author":"Kirov","year":"2024","journal-title":"Am. J. Cardiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00059-021-05040-3","article-title":"Effects of oral colchicine administration as first-line adjunct therapy in myopericarditis","volume":"47","author":"Duran","year":"2022","journal-title":"Herz"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/eurjpc\/zwaf143","article-title":"Colchicine mitigates arterial stiffness in high-risk patients with type 2 diabetes: A randomized placebo-controlled trial","volume":"33","author":"Baier","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ehjci\/jeag028","article-title":"Effect of colchicine on progression of known coronary atherosclerosis in patients with stable coronary artery disease: EKSTROM randomized placebo controlled trial","volume":"27","author":"Budoff","year":"2026","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_125","first-page":"84","article-title":"Colchicine for Preserving Left Ventricular Systolic Function in Patients with STEMI Following Successful Primary PCI: A Speckle-Tracking Echocardiography Study","volume":"25","author":"Mostafa","year":"2024","journal-title":"Iran. Heart J."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40119-024-00393-2","article-title":"The Effect of Colchicine on Platelet Function Profiles in Patients with Stable Coronary Artery Disease: The ECLIPSE Pilot Study","volume":"14","author":"Seecheran","year":"2025","journal-title":"Cardiol. Ther."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s10557-021-07239-2","article-title":"Colchicine-Containing Nanoparticles Attenuates Acute Myocardial Infarction Injury by Inhibiting Inflammation","volume":"36","author":"Wang","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.carrev.2022.06.017","article-title":"Colchicine and Quality of Life in Patients with Acute Coronary Syndromes: Results from the COPS Randomized Trial","volume":"44","author":"Dawson","year":"2022","journal-title":"Cardiovasc. Revasc. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5152\/AnatolJCardiol.2021.707","article-title":"Colchicine for cardiovascular therapy: A drug interaction perspective and a safety meta-analysis","volume":"25","author":"Sen","year":"2021","journal-title":"Anatol. J. Cardiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"132068","DOI":"10.1016\/j.ijcard.2024.132068","article-title":"Efficacy and safety of colchicine for atrial fibrillation prevention: An updated meta-analysis of randomized controlled trials","volume":"406","author":"Tian","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s43044-024-00515-0","article-title":"Studying the efficacy of low-dose colchicine on clinical outcomes of patients with STEMI: A randomized controlled trial","volume":"76","author":"Yousefzadeh","year":"2024","journal-title":"Egypt. Heart J."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MCA.0000000000001220","article-title":"Meta-analysis of the effect of colchicine on C-reactive protein in patients with acute and chronic coronary syndromes","volume":"34","author":"Alam","year":"2023","journal-title":"Coron. Artery Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"8646351","DOI":"10.1155\/2024\/8646351","article-title":"Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular Disease","volume":"2024","author":"Akl","year":"2024","journal-title":"J. Interv. Cardiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MCA.0000000000000931","article-title":"Colchicine therapy in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials","volume":"32","author":"Barbarawi","year":"2021","journal-title":"Coron. Artery Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/rheumatology\/kead625","article-title":"Colchicine: The good, the bad, the ugly and how to minimize the risks","volume":"63","author":"Stamp","year":"2024","journal-title":"Rheumatology"},{"key":"ref_138","first-page":"1929","article-title":"The Trials of Interpreting Clinical Trials-A Bayesian Perspective on Colchicine After an Acute Coronary Syndrome","volume":"41","author":"Brophy","year":"2025","journal-title":"Can. J. Cardiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40119-025-00440-6","article-title":"Colchicine Among Patients with Acute Coronary Syndrome: A Meta-Analysis of Randomized Trials","volume":"15","author":"Hamed","year":"2026","journal-title":"Cardiol. Ther."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.amjcard.2023.07.029","article-title":"Major Adverse Cardiovascular Events After Colchicine Administration Before Percutaneous Coronary Intervention: Follow-Up of the Colchicine-PCI Trial","volume":"204","author":"Shah","year":"2023","journal-title":"Am. J. Cardiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4419\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:44:38Z","timestamp":1779115478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":140,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27104419"],"URL":"https:\/\/doi.org\/10.3390\/ijms27104419","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]}}}